Eagle Pharmaceuticals Depreciation & Amortization 2011-2026 | EGRX

Annual Depreciation & Amortization Eagle Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
646 K	764 K	872 K	972 K	1.16 M	932 K	641 K	112 K	104 K	135 K	240 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.16 M	104 K	598 K

Quarterly Depreciation & Amortization Eagle Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
100 K	100 K	-	200 K	200 K	200 K	-	200 K	200 K	200 K	-	196 K	209 K	251 K	-	241 K	241 K	242 K	-	918 K	683 K	341 K	-	657 K	432 K	196 K	-	461 K	296 K	140 K	-	31 K	22 K	12 K	13 K	73 K	51 K	29 K	31 K	105 K	78.5 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
918 K	12 K	223 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.08	-0.23 %	$ 116 M	Canada
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Evolus EOLS	7.51 M	$ 6.13	9.66 %	$ 395 M	USA
China Pharma Holdings CPHI	2.62 M	$ 0.58	-	$ 10.1 M	China
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.74	1.91 %	$ 52.6 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Harrow Health HROW	1.32 M	$ 38.84	-0.97 %	$ 1.43 B	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Emergent BioSolutions EBS	125 M	$ 8.55	-2.51 %	$ 438 M	USA
Assertio Holdings ASRT	28.2 M	$ 11.99	-0.66 %	$ 852 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.67	0.8 %	$ 2.07 B	Canada
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Organogenesis Holdings ORGO	13.6 M	$ 2.92	1.74 %	$ 384 M	USA
Perrigo Company plc PRGO	338 M	$ 11.59	-0.86 %	$ 1.61 B	USA
TherapeuticsMD TXMD	922 K	$ 2.17	0.46 %	$ 22.7 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Veru VERU	268 K	$ 2.51	-	$ 339 M	USA
Viatris VTRS	2.74 B	$ 14.56	-1.05 %	$ 17.5 B	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Rockwell Medical RMTI	1.44 M	$ 0.88	-1.56 %	$ 20.5 M	USA
cbdMD YCBD	452 K	$ 0.76	-1.04 %	$ 3.28 M	USA
Pacira BioSciences PCRX	78.8 M	$ 23.08	0.96 %	$ 1.07 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 4.47	-6.29 %	$ 135 M	USA
SCYNEXIS SCYX	580 K	$ 0.77	-1.29 %	$ 38.4 M	USA
Solid Biosciences SLDB	2.46 M	$ 5.76	-6.19 %	$ 235 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.77	-1.07 %	$ 3.44 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Tilray TLRY	35.7 M	$ 7.35	0.62 %	$ 4.54 B	Canada
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA